Skip to nav Skip to content
Wayne  Cruse

Wayne Cruse, MD

4.9 (255)

Specialty: Plastic Surgery

Program: Reconstructive Oncology

  • Overview

    Cancer Focus:
    Basal Cell Carcinoma, Melanoma, Merkel Cell Carcinoma, Squamous Cell Carcinoma

      Dr. Wayne Cruse is a plastic surgeon and a Senior Member of the Department of Cutaneous Oncology at Moffitt Cancer Center.  He is a Professor of Plastic Surgery and Professor of Oncologic Sciences at the Morsani College of Medicine at the University of South Florida. He is the Juan C. Bolivar Endowed Chair in Surgical Oncology at the University.  His clinical and research interests include cutaneous oncology, melanoma, Merkel cell cancer, basal cell cancer, squamous cell cancer, sarcoma, cancer reconstruction, wounds, and burn care.  Dr. Cruse received his medical degree from the University of Louisville School of Medicine. He completed a residency in Surgery at the University of South Florida and then a residency in Plastic Surgery at the University of Kentucky. He is certified by and a Diplomate of the American Board of Plastic Surgery. Dr. Cruse has been affiliated with Moffitt Cancer Center since 1986. He was Medical Director of the Tampa General Hospital Burn Center for 25 years. He is a member of numerous professional organizations, including the American Association of Plastic Surgeons, the American Society of Plastic Surgeons, and the Society of Surgical Oncology. He has been a speaker at numerous medical conferences and has multiple publications. His treatment principles include a focus on precision and skill in surgical procedures related to skin cancer removal and adhering to the established guidelines of the National Comprehensive Cancer Network and the Cutaneous Oncology Program of the Moffitt Cancer Center and Research Institute. These organizations provide evidence-based recommendations for the diagnosis and treatment of skin cancer. In addition, he considers functional and cosmetic issues aiming to achieve the best possible result in terms of appearance while maintaining function. In summary, his commitment is to high-quality surgical procedures aligned with established guidelines, and an approach that optimizes both functional and cosmetic outcomes.  

    Education & Training

    Residency:

    • University of Kentucky - Plastic Surgery
    • University of South Florida - Surgery

    Medical School:

    • University of Louisville - MD
  • Publications

    • Foster KW, Robinson SK, Tung-Hahn E, Gibbons G, Cruse CW, Mudaliar K, Tung R, Kim W. Multifocal Langerhans Cell Histiocytosis: A Unique Presentation of Eosinophilic Granuloma with Intracranial Extension, Massive Lymphadenopathy, and Epstein-Barr Viral Infection in an Adolescent Female. Case Rep Dermatol. 2021 Jan.13(1):28-35. Pubmedid: 33613231. Pmcid: PMC7879306.
    • Shanks A, Laun J, Holstein A, Varshney S, Messina J, Cruse CW. A rare concurrence of Muir-Torre-associated sebaceous carcinoma in the setting of a lipedematous scalp. Case Reports Plast Surg Hand Surg. 2020 Oct.7(1):124-129. Pubmedid: 33178881. Pmcid: PMC7594736.
    • Weinstein B, Henderson-Jackson E, Cruse CW, Brohl AS. PIK3CA-Related Overgrowth Syndrome (PROS) and Angiosarcoma: A Case Report. Eplasty. 2020 Apr.20:ic6. Pubmedid: 32362992. Pmcid: PMC7180201.
    • Clayman E, Billington A, Cruse CW. Full-thickness Pediatric Burn following Reaction between Cyanoacrylate Nail Adhesive and Cotton Shirt. J Cutan Aesthet Surg. 2019 Jan.13(1):35-37. Pubmedid: 32655249. Pmcid: PMC7335472.
    • Perez MC, Oliver DE, Weitman ES, Boulware D, Messina JL, Torres-Roca J, Cruse CW, Gonzalez RJ, Sarnaik AA, Sondak VK, Wuthrick EJ, Harrison LB, Zager JS. Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?. Ann Surg Oncol. 2019 Feb.26(2):379-385. Pubmedid: 30311164. Pmcid: PMC7771265.
    • Weitman ES, Perez MC, Lee D, Kim Y, Fulp W, Sondak VK, Sarnaik AA, Gonzalez RJ, Cruse CW, Messina JL, Zager JS. Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins. Melanoma Manag. 2019 Apr.6(2):MMT17. Pubmedid: 31406562. Pmcid: PMC6688556.
    • Perez MC, de Pinho FR, Holstein A, Oliver DE, Naqvi SMH, Kim Y, Messina JL, Burke E, Gonzalez RJ, Sarnaik AA, Cruse CW, Wuthrick EJ, Harrison LB, Sondak VK, Zager JS. Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?. Ann Surg Oncol. 2018 Oct.25(11):3334-3340. Pubmedid: 30073600. Pmcid: PMC7771268.
    • Holmes JH, Molnar JA, Carter JE, Hwang J, Cairns BA, King BT, Smith DJ, Cruse CW, Foster KN, Peck MD, Sood R, Feldman MJ, Jordan MH, Mozingo DW, Greenhalgh DG, Palmieri TL, Griswold JA, Dissanaike S, Hickerson WL. A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries. J Burn Care Res. 2018 Aug.39(5):694-702. Pubmedid: 29800234. Pmcid: PMC6097595.
    • Kordahi AM, Elston JB, Robertson EM, Cruse CW. Desmoplastic Melanoma. Eplasty. 2017 Sep.17:ic23. Pubmedid: 28943995. Pmcid: PMC5608073.
    • Glazer ES, Porubsky CF, Francis JD, Ibanez J, Castner N, Messina JL, Sarnaik AA, Harrington MA, Cruse CW, Sondak VK, Zager JS. Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions. Ann Plast Surg. 2017 Jun.78(6):663-667. Pubmedid: 27984218. Pmcid: PMC5425303.
    • Doepker MP, Yamamoto M, Applebaum MA, Patel NU, Jaime Montilla-Soler M, Sarnaik AA, Wayne Cruse C, Sondak VK, Zager JS. Comparison of Single-Photon Emission Computed Tomography-Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies. Ann Surg Oncol. 2017 Feb.24(2):355-361. Pubmedid: 27660259. Pmcid: PMC5955617.
    • Strom T, Carr M, Zager JS, Naghavi A, Smith FO, Cruse CW, Messina JL, Russell J, Rao NG, Fulp W, Kim S, Torres-Roca JF, Padhya TA, Sondak VK, Trotti AM, Harrison LB, Caudell JJ. Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma. Ann Surg Oncol. 2016 Oct.23(11):3572-3578. Pubmedid: 27251134.
    • Yacoub A, Soni KK, Mojica L, Mai J, Morano J, Cruse CW, Sandin RL, Nanjappa S, Bohra C, Gajanan G, Greene JN. Primary Gangrenous Cutaneous Mold Infections in a Patient With Cancer and Neutropenia. Cancer Control. 2016 Jul.23(3):265-271. Pubmedid: 27556666.
    • Riccio C, King K, Elston JB, Harrington MA, Cruse CW. Bilateral Plantar Verrucous Carcinoma. Eplasty. 2016 Dec.16:ic46. Pubmedid: 28035248. Pmcid: PMC5155315.
    • Smith FO, Yue B, Marzban SS, Walls BL, Carr M, Jackson RS, Puleo CA, Padhya T, Cruse CW, Gonzalez RJ, Sarnaik AA, Schell MJ, DeConti RC, Messina JL, Sondak VK, Zager JS. Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma. Cancer. 2015 Sep.121(18):3252-3260. Pubmedid: 26038193. Pmcid: PMC4904725.
    • Yamamoto M, Fisher KJ, Wong JY, Koscso JM, Konstantinovic MA, Govsyeyev N, Messina JL, Sarnaik AA, Cruse CW, Gonzalez RJ, Sondak VK, Zager JS. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma. Cancer. 2015 May.121(10):1628-1636. Pubmedid: 25677366. Pmcid: PMC4515965.
    • Han D, Han G, Zhao X, Rao NG, Messina JL, Marzban SS, Sarnaik AA, Cruse CW, Sondak VK, Zager JS. Clinicopathologic predictors of survival in patients with desmoplastic melanoma. PLoS One. 2015 Mar.10(3):e0119716. Pubmedid: 25811671. Pmcid: PMC4374691.
    • Ching JA, Curtis HL, Braue JA, Kudchadkar RR, Mendoza TI, Messina JL, Cruse CW, Smith DJ, Harrington MA. The impact of neoadjuvant hedgehog inhibitor therapy on the surgical treatment of extensive basal cell carcinoma. Ann Plast Surg. 2015 Jun.74 Suppl 4:S193-S197. Pubmedid: 25695449.
    • Dossett LA, Harrington M, Cruse CW, Gonzalez RJ. Cutaneous angiosarcoma. Curr Prob Cancer. 2015 Aug.39(4):258-263. Pubmedid: 26276214.
    • Ching JA, Curtis HL, Braue JA, Kudchadkar R, Mendoza TI, Messina JL, Cruse CW, Harrington MA. The impact of neoadjuvant hedgehog inhibitor therapy on the surgical treatment of extensive Basal cell carcinoma. Plast Reconstr Surg. 2014 Oct.134(4 Suppl 1):138-139. Pubmedid: 25254869.
    • Strom T, Caudell JJ, Han D, Zager JS, Yu D, Cruse CW, Marzban SS, Messina JL, Trotti AM, Sondak VK, Rao NG. Radiotherapy influences local control in patients with desmoplastic melanoma. Cancer. 2014 May.120(9):1369-1378. Pubmedid: 24142775. Pmcid: PMC4515972.
    • Perez MC, Padhya TA, Messina JL, Jackson RS, Gonzalez RJ, Bui MM, Letson GD, Cruse CW, Lavey RS, Cheong D, Forster MR, Fulp WJ, Sondak VK, Zager JS. Cutaneous angiosarcoma: a single-institution experience. Ann Surg Oncol. 2013 Oct.20(11):3391-3397. Pubmedid: 23835652. Pmcid: PMC4509495.
    • Troy J, Karlnoski R, Downes K, Brown KS, Cruse CW, Smith DJ, Payne WG. The Use of EZ Derm® in Partial-Thickness Burns: An Institutional Review of 157 Patients. Eplasty. 2013 Apr.13:e14. Pubmedid: 23573334. Pmcid: PMC3593337.
    • Han D, Yu D, Zhao X, Marzban SS, Messina JL, Gonzalez RJ, Wayne Cruse C, Sarnaik AA, Puleo C, Sondak VK, Zager JS. Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm. Ann Surg Oncol. 2012 Oct.19(11):3335-3342. Pubmedid: 22766986. Pmcid: PMC4504019.
    • Deneve JL, Messina JL, Marzban SS, Gonzalez RJ, Walls BM, Fisher KJ, Ann Chen Y , Wayne Cruse C, Sondak VK, Zager JS. Merkel cell carcinoma of unknown primary origin. Ann Surg Oncol. 2012 Jul.19(7):2360-2366. Pubmedid: 22271206. Pmcid: PMC4504007.
    • Gonzalez RJ, Padhya TA, Cherpelis BS, Prince MD, Aya-Ay ML, Sondak VK, Cruse CW, Zager JS. The surgical management of primary and metastatic Merkel cell carcinoma. Curr Prob Cancer. 2010 Jan.34(1):77-96. Pubmedid: 20371076.
    • Messina J, Möller MG, Sondak VK, Glass FL, Cruse CW. The contoured staged marginal and central surgical excision technique with en face histopathological analysis: useful additions in the armamentarium for treating and diagnosing melanoma in situ. Ann Surg Oncol. 2009 Sep.16(9):2654-2655. Pubmedid: 19588203.
    • Möller MG, Pappas-Politis E, Zager JS, Santiago LA, Yu D, Prakash A, Kinal A, Clark GS, Zhu W, Puleo CA, Glass LF, Messina JL, Sondak VK, Cruse CW. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol. 2009 Jun.16(6):1526-1536. Pubmedid: 19050971.
    • Raziano RM, Clark GS, Cherpelis BS, Sondak VK, Cruse CW, Fenske NA, Glass LF. Staged margin control techniques for surgical excision of lentigo maligna. G Ital Dermatol Venereol. 2009 Jun.144(3):259-270. Pubmedid: 19528907.
    • Rollison D, Pawlita M, Giuliano A, Iannacone M, Sondak V, Messina J, Cruse C, Fenske N, Glass L, Kienstra M, Michael K, Waterboer T, Gheit T, Tommasino M. Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer. 2008 Nov.123(10):2337-2342. Pubmedid: 18729188.
    • Lewis J, Zager J, Yu D, Pelaez D, Riker A, Dessureault S, Cruse C, Reintgen D, Puleo C, Sondak V. Full-thickness grafts procured from skin overlying the sentinel lymph node basin; reconstruction of primary cutaneous malignancy excision defects. Ann Surg Oncol. 2008 Jun.15(6):1733-1740. Pubmedid: 18379848.
    • Clark G, Pappas-Politis E, Cherpelis B, Messina J, Moller M, Cruse C, Glass L. Surgical management of melanoma in situ on chronically sun-damaged skin. Cancer Control. 2008 Jul.15(3):216-224. Pubmedid: 18596673.
    • Rainey S, Cruse CW, Smith JS, Smith KR, Jones D, Cobb S. The occurrence and seasonal variation of accelerant-related burn injuries in central Florida. J Burn Care Res. 2007 Sep.28(5):675-680. Pubmedid: 17667487.
    • Puleo C, Messina J, Riker A, Glass L, Nelson C, Cruse C, Johnson T, Sondak V. Sentinel node biopsy for thin melanomas: which patients should be considered?. Cancer Control. 2005 Oct.12(4):230-235. Pubmedid: 16258494.
    • Pu L, Cruse C, Wells K, Shons A, Reintgen D. Superficial femoral lymph node dissection after positive sentinel lymphadenectomy for early-stage melanoma of the lower extremity. Ann Plast Surg. 2003 Jul.51(1):69-76. Pubmedid: 12838128.
    • Pu LL, Wells KE, Cruse CW, Shons AR, Reintgen DS. Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the head and neck. Plast Reconstr Surg. 2003 Jul.112(1):43-49. Pubmedid: 12832875.
    • Reintgen D, Cruse CW, Atkins M. Cutaneous malignant melanoma. Clin Dermatol. 2001 May.19(3):253-261. Pubmedid: 11479037.
    • Costello D, Powers A, Lynn J, Cruse C, Reintgen D. Surgical management of primary melanoma. Curr Oncol Rep. 2000 Jul.2(4):307-313. Pubmedid: 11122858.
    • Smith D, Messina J, Perrott R, Berman C, Reintgen D, Cruse C, Glass F, DeConti R, Trotti A, Fenske N. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control. 2000 Jan.7(1):72-83. Pubmedid: 10740663.
    • Pu LL, Cruse CW, Wells KE, Cantor A, Glass LF, Messina JL, Reintgen DS. Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg. 1999 Sep.104(4):964-969. Pubmedid: 10654734.
    • Haddad FF, Stall A, Messina J, Brobeil A, Ramnath E, Glass LF, Cruse CW, Berman CG, Reintgen DS. The progression of melanoma nodal metastasis is dependent on tumor thickness of the primary lesion. Ann Surg Oncol. 1999 Mar.6(2):144-149. Pubmedid: 10082038.
    • Reintgen D, Cruse C, Wells K. The next revolution in general surgery: radioguided surgery. Ann Surg Oncol. 1999 Mar.6(2):125-126. Pubmedid: 10082030.
    • Messina J, Glass L, Cruse C, Berman C, Ku N, Reintgen D. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol. 1999 Jun.23(6):686-690. Pubmedid: 10366151.
    • Kamath D, Milotes G, Lyman G, Rapaport D, Cruse C, Glass F, Fenske N, Messina J, Berman C, Reintgen D. Cutaneous lymphatic drainage in patients with grossly involved nodal basins. Ann Surg Oncol. 1999 Jun.6(4):345-349. Pubmedid: 10379854.
    • Brobeil A, Cruse CW, Messina JL, Glass LF, Haddad FF, Berman CG, Marshburn J, Reintgen DS. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma. Surg Oncol Clin N Am. 1999 Jul.8(3):435-45, viii. Pubmedid: 10448688.
    • Pu LL, Cruse CW. Lymphatic mapping and sentinel lymph node biopsy for nonmelanoma skin cancers. Surg Oncol Clin N Am. 1999 Jul.8(3):527-39, x. Pubmedid: 10448695.
    • Joseph E, Brobeil A, Cruse C, Wells K, Costello D, Reintgen D. Lymphatic mapping for melanomas of the upper extremity. J Hand Surg Am. 1999 Jul.24(4):675-681. Pubmedid: 10447156.
    • Wells K, Stadelmann W, Rapaport D, Hamlin R, Cruse C, Reintgen D. Parotid selective lymphadenectomy in malignant melanoma. Ann Plast Surg. 1999 Jul.43(1):1-6. Pubmedid: 10402980.
    • Powers P, Sarkar S, Goldgof D, Cruse C, Tsap L. Scar assessment: current problems and future solutions. J Burn Care Rehabil. 1999 Jan.20(1 Pt 1):54-60. Pubmedid: 9934638.
    • Joseph E, Glass F, Glass J, Messina J, DeConti R, Cruse C, Rapaport D, Berman C, Fenske N, Reintgen D. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol. 1998 Mar.5(2):119-125. Pubmedid: 9527264.
    • Brobeil A, Berman C, Cruse C, DeConti R, Cantor A, Lyman G, Rapaport D, Joseph E, Wells K, Reintgen D. Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma. Ann Surg Oncol. 1998 Jun.5(4):376-383. Pubmedid: 9641461.
    • Javaheri S, Cruse C, Stadelmann W, Reintgen D. Sentinel node excision for the diagnosis of metastatic neuroendocrine carcinoma of the skin: a case report. Ann Plast Surg. 1997 Sep.39(3):299-302. Pubmedid: 9326712.
    • Wells K, Rapaport D, Cruse C, Payne W, Albertini J, Berman C, Lyman G, Reintgen D. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997 Sep.100(3):591-594. Pubmedid: 9283554.
    • Ramnath E, Kamath D, Brobeil A, Stall A, Kamath V, Cruse C, Glass F, Messina J, Fenske N, Berman C, Cantor A, Cuthbertson D, Reintgen D, Ross M. Lymphatic Mapping for Melanoma: Long-term Results of Regional Nodal Sampling With Radioguided Surgery. Cancer Control. 1997 Nov.4(6):483-490. Pubmedid: 10763056.
    • Reintgen D, Albertini J, Milliotes G, Marshburn J, Cruse C, Rapaport D, Berman C, Glass L, Fenske N, Einstein, Jr. A, Lyman G. Investment in new technology research can save future health care dollars. J Fla Med Assoc. 1997 Mar.84(3):175-181. Pubmedid: 9143169.
    • Brobeil A, Kamath D, Cruse CW, Rapaport DP, Wells KE, Shons AR, Messina JL, Glass LF, Berman CG, Puleo CA, Reintgen DS. The clinical relevance of sentinel lymph nodes identified with radiolymphoscintigraphy. J Fla Med Assoc. 1997 Mar.84(3):157-160. Pubmedid: 9143166.
    • Kamath D, Rapaport D, DeConti R, Cruse C, Wells K, Glass L, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reintgen D. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc. 1997 Mar.84(3):182-187. Pubmedid: 9143170.
    • Kamath D, Cantor A, Glass L, Fenske N, Cruse C, Wells K, Rapaport D, DeConti R, Messina J, Reintgen D. Florida's undeclared epidemic: malignant melanoma. J Fla Med Assoc. 1997 Mar.84(3):161-165. Pubmedid: 9143167.
    • Messina J, Reintgen D, Cruse C, Rapaport D, Berman C, Fenske N, Glass L. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol. 1997 Jul.4(5):389-395. Pubmedid: 9259965.
    • Cruse CW, Reintgen D, Glass F, Messina J, Trotti A, DeConti R, Wells K. Neuroendocrine Carcinoma of the Skin. Cancer Control. 1997 Jul.4(4):346-348. Pubmedid: 10763041.
    • Stadelmann W, Cruse C, Javaheri S, Reintgen D. The use of selective lymphadenectomy in squamous cell carcinoma of the wrist: a case report. J Hand Surg Am. 1997 Jul.22(4):726-731. Pubmedid: 9260634.
    • Brobeil A, Rapaport D, Wells K, Cruse C, Glass F, Fenske N, Albertini J, Miliotis G, Messina J, DeConti R, Berman C, Shons A, Cantor A, Reintgen D. Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Ann Surg Oncol. 1997 Jan.4(1):19-23. Pubmedid: 8985513.
    • Reintgen D, Glass F, Fenske N, Cruse CW, Rapaport D, Messina J, Wells KE, DeConti R, Marshburn J. Clinical Practice Guidelines for Melanoma. Cancer Control. 1997 Jan.4(1):45-52. Pubmedid: 10763004.
    • Berger D, Fieg B, Podoloff D, Norman, Jr. J, Cruse C, Reintgen D, Ross M. Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma. Ann Surg Oncol. 1997 Apr.4(3):247-251. Pubmedid: 9142386.
    • Lynch C, Pinelli D, Cruse C, Spellacy W, Sinnott J, Shashy R. Maternal death from postpartum necrotizing fascitis arising in an episiotomy: a case report. Infect Dis Obst Gyn. 1997.341-344. Pubmedid: noPMID.
    • Cruse C, Reintgen D, Glass F, Messina J, Trotti, III A, DeConti R. Clinical practice guidelines: neuroendocrine tumors of the skin. Cancer Control. 1997.4:258-260. Pubmedid: noPMID.
    • Polo M, Ko F, Busillo F, Cruse C, Krizek T, Robson M. Cytokine production in patients with hypertrophic burn scars. J Burn Care Rehabil. 1997.18(6):477-482. Pubmedid: 9404979.
    • Rapaport D, Stadelmann W, Wells K, Cruse C, Hamlin R, Reintgen D. Parotid gland sentinel lymphadenectomy in malignant melanoma. Melanoma Res. 1997.7:1-6. Pubmedid: noPMID.
    • Lynch CM, Pinelli DM, Cruse CW, Spellacy WN, Sinnott JT, Shashy RG. Maternal death from postpartum necrotizing fasciitis arising in an episiotomy: a case report. Infect Dis Obstet Gynecol. 1997.5(5):341-344. Pubmedid: 18476182. Pmcid: PMC2364577.
    • Milotes G, Lyman G, Cruse C, Puleo C, Albertini J, Rapaport D, Glass L, Fenske N, Soriano T, Cuny C, VanVoorhis N, Reintgen D. Evaluation of new putative tumor markers for melanoma. Ann Surg Oncol. 1996 Nov.3(6):558-563. Pubmedid: 8915488.
    • Meliotis G, Albertini J, Berman C, Heller R, Messina J, Glass L, Cruse C, Rapaport D, Puleo C, Fenske N, Petsofglov C, DeConti R, Lyman G. The tumor biology of melanoma nodal metastases. Am Surg. 1996 Jan.62(1):81-88. Pubmedid: 8540654.
    • Albertini J, Cruse C, Rapaport D, Wells K, DeConti R, Berman C, Jared K, Messina J, Lyman G, Glass L, Fenske N, Reintgen D. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996 Feb.223(2):217-224. Pubmedid: 8597518. Pmcid: PMC1235100.
    • Glass LF, Messina JL, Cruse W, Wells K, Rapaport D, Miliotes G, Berman C, Reintgen D, Fenske NA. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996 Aug.22(8):715-720. Pubmedid: 8780765.
    • Glass L, Fenske N, Messina J, Cruse C, Rapaport D, Berman C, Puleo C, Heller R, Miliotes G, Albertini J, Reintgen D. The role of selective lymphadenectomy in the management of patients with malignant melanomoa. Dermatol Surg. 1996.21:979-983.
    • Reintgen D, Albertini J, Berman C, Cruse C, Fenske N, Glass L, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. Accurate Nodal Staging of Malignant Melanoma. Cancer Control. 1995 Oct.2(5):405-414. Pubmedid: 10862181.
    • Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, Puleo CA, Heller R, Miliotes G, Albertini J. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Dermatol Surg. 1995 Nov.21(11):979-983. Pubmedid: 7582838.
    • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J, et a. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb.61(2):97-101. Pubmedid: 7856986 .
    • Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J. The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995 Feb.61(2):97-101. Pubmedid: 7856986.
    • Stadelmann W, Cruse C, Messina J. Synovial cell sarcoma of the temporomandibular joint. Ann Plast Surg. 1995 Dec.35(6):664-668. Pubmedid: 8748354.
    • Reintgen D, Albertini J, Miliotes G, Berman C, Cruse C, Fenske N, Glasser S, Puleo C, Wang X, Wells K, Rapaport D, DeConti R, Messina J, Heller R. The accurate staging and modern day treatment of malignant melanoma. Cancer Res Ther Cont. 1995.4:183-197. Pubmedid: noPMID.
    • Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reintgen DS. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol. 1994 Nov.1(6):487-494. Pubmedid: 7850555.
    • Wang X, Heller R, VanVoorhis N, Cruse CW, Glass F, Fenske N, Berman C, Leo-Messina J, Rappaport D, Wells K, Deconti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994 Dec.220(6):768-774. Pubmedid: 7986144. Pmcid: PMC1234479.
    • Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, Heller R, Ross M, Lyman G. The orderly progression of melanoma nodal metastases. Ann Surg. 1994 Dec.220(6):759-767. Pubmedid: 7986143. Pmcid: PMC1234478.
    • Wells KE, Cruse CW, Baker JL, Daniels SM, Stern RA, Newman C, Seleznick MJ, Vasey FB, Brozena S, Albers SE. The health status of women following cosmetic surgery. Plast Reconstr Surg. 1994 Apr.93(5):907-912. Pubmedid: 8134482.
    • Wells KE, Cruse CW, Daniels S, Berman C, Norman J, Reintgen DS. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg. 1994 Apr.93(4):757-761. Pubmedid: 8134434.
    • Reintgen D, Cruse C, Wells K, Berman C, Fenske N, Glass L, Schroer K, Heller R, Ross M, Lyman G, Cox C, Rapaport D, Seigler H, Balch C. The orderly progression of melanoma nodal metastases. Ann Surg. 1994.220(6):759-767.
    • Wells K, Cruse C, Daniels S, Berman C, Norman Jr. J, Reintgen D. The use of lymphoscintigraphy in melanoma of the head and neck. Plast Reconstr Surg. 1994.93:757-761.
    • Wang X, Heller R, Cruse C, VanVoorhis N, Glass L, Fenske N, Berman C, Leo-Messina J, Rapaport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metasases with polymerase chain reaction in patients with malignant melanoma. Ann Surg. 1994.220:768-774.
    • Powers P, Cruse C, Daniels S, Stevens B. Posttraumatic stress disorder in patients with burns. J Burn Care Rehabil. 1994.15(2):147-153.
    • Austin P, Cruse C, Lyman G, Schroer K, Glass L, Reintgen D. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol. 1994.1(6):487-494.
    • Wells K, Cruse C, Baker J, Daniels S, Stern R, Newman C, Seleznick M, Vasey F, Brozena S, Albers S, Fenske N. The health status of women following cosmetic surgery. Plast Reconstr Surg. 1994.93:907-912.
    • McAllister E, Wells K, Chaet M, Norman Jr. J, Cruse C. Perineal reconstruction after surgical extirpation of pelvic malignancies using the transpelvic transverse rectus abdominal myocutaneous flap. Ann Surg Oncol. 1994.1(2):164-168.
    • Cruse CW, Reintgen D. Treatment of the primary malignant melanoma: a review. Semin Surg Oncol. 1993 May.9(3):215-218. Pubmedid: 8516606.
    • Reintgen D, Cruse CW, Schroer K, Glass F, Saba H, Puleo C, King J, Berman C, Hannon L, Cox C. Computer database for melanoma: a clinical management and research tool to ensure continuous quality assessment. Semin Surg Oncol. 1993 May.9(3):208-214. Pubmedid: 8516605.
    • Powers PS, Cruse CW, Daniels S, Stevens BA. Safety and efficacy of debridement under anesthesia in patients with burns. J Burn Care Rehabil. 1993 Mar.14(2 Pt 1):176-180. Pubmedid: 8501106.
    • Heller R, King B, Baekey P, Cruse C, Reintgen D. The identification of submicroscopic lymph node metastases in patients with malignant melanoma. Semin Surg Oncol. 1993.9:285-289.
    • Reintgen D, Cruse C, Schroer K, Glass L, Saba H, Puleo C, King J, Berman C, Hannon L, Cox C. Computer database for melanoma: a clinical management and research tool to ensure continuous quality assessment. Semin Surg Oncol. 1993.9:208-214.
    • Reintgen D, Cruse C, Berman C, Norman Jr. J. A redefinition of skin mapping with the use of lymphoscintigraphy: implications for elective lymph node dissection for melanoma. Melanoma Res. 1993.3:34-34.
    • Norman Jr. J, Wells K, Kearney R, Cruse C, Berman C, Reintgen D. Identification of lymphatic basins in patients with cutaneous melanoma. Semin Surg Oncol. 1993.9:224-227.
    • Cruse C, Reintgen D. The treatment of the primary malignant melanoma: a review. Semin Surg Oncol. 1993.9:215-218.
    • Powers P, Cruse C, Daniels S, Stevens B. Safety and efficacy of debridement under anesthesia in burn patients. J Burn Care Rehabil. 1993.14(2):176-180.
    • Zeller J, Sturm G, Cruse C. Patients with burns are successful in work hardening programs. J Burn Care Rehabil. 1993.14(2):189-196. Pubmedid: 8501108.
    • Stankard CE, Cruse C, Wells K, Karl R. Chronic pressure ulcer carcinomas. Ann Plast Surg. 1993.30(3):274-277.
    • Cruse CW, O'Neill W, Rayhack J. Metastatic basal cell carcinoma of the upper extremity. J Hand Surg Am. 1992 Nov.17(6):1093-1094. Pubmedid: 1430947.
    • Berman CG, Norman J, Cruse CW, Reintgen DS, Clark RA. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992 Jan.28(1):29-32. Pubmedid: 1642403.
    • Reintgen D, Cruse CW, Wells K, Stankard C, Saba H, Schroer K, Cox C, Berman C, Glass F, Alvarez L. The effectiveness of skin cancer screening and continuing medical education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol. 1992 Dec.1(6):379-384. Pubmedid: 1341274.
    • Cruse C, O'Neill W, Rayhack J. Metastatic basal cell carcinoma of the upper extremity. J Hand Surg. 1992.17(6):1093-1094.
    • Moye S, Cruse C. Bilateral axillary ectopic breast tissue case report and review of the literature. Breast Dis. 1992.5:51-54.
    • Berman C, Norman Jr. J, Cruse C, Reintgen D, Clark R. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992.28(1):29-32.
    • Stankard C, Cruse C, Cox C, Wells K, King J, Reintgen D. The concept of lymph node dissections in patients with malignant melanoma. Ann Plast Surg. 1992.28:33-38.
    • Saba H, Cruse C, Wells K, Klein C, Wood H, Reintgen D. Adjuvant chemotherapy in malignant melanoma using DTIC, BCNU, cisplatin and tamoxifen. Ann Plast Surg. 1992.28:60-65.
    • Cruse C, Wells K, Reintgen D. Treatment of the primary in malignant melanoma of the skin. Ann Plast Surg. 1992.28(1):22-25.
    • Reintgen D, Cruse C, Wells K, Stankard C, Saba H, Schroer K, Cox C, Berman C, Glass L, Alvarez L, Brozena S, Fenske N, Fabri P. The effectiveness of skin cancer screening and continuing education programs toward increasing the survival of patients with malignant melanoma. Surg Oncol. 1992.1:379-384.
    • Cruse C, Wells K, Schroer K, Reintgen D. Etiology and prognosis of local recurrence in malignant melanoma. Ann Plast Surg. 1992.28:26-28.
    • Reintgen D, Cruse C, Wells K, Saba H, Fabri P. The evaluation of putative tumor markers for malignant melanoma. Ann Plast Surg. 1992.28:55-59.
    • Reintgen D, Cruse C, Wells K, Saba H, Slingluff. Isolated limb perfusion for recurrent melanoma of the extremity. Ann Plast Surg. 1992.28:50-54.
    • Wells K, Reintgen D, Cruse C. The current management and prognosis of acral lentiginous melanoma. Ann Plast Surg. 1992.28:100-103.
    • Riggs D, Weibley R, Daniels S, Wells K, Cruse C. Hot embers and ashes as a source of burns in children. Am J Dis Child. 1992.146:657-658.
    • Saba H, Cruse C, Wells K, Klein C, Reintgen D. Malignant melanoma with dacarbazine, carmustine, cisplatin, and tamoxifen regimens: a University of South Florida and H. Lee Moffitt melanoma center study. Ann Plast Surg. 1992.28(1):65-69.
    • Heller R, Becker J, Wasselle J, Baekey P, Cruse C, Cox C. Detection of occult lymph node metastases in malignant melanoma. Ann Plast Surg. 1992.28(1):74-77.
    • Norman Jr. J, Cruse C, Wells K, Saba H, Reintgen D. Metastatic melanoma with an unknown primary. Ann Plast Surg. 1992.28(1):81-84.
    • Norman J, Cruse CW, Espinosa C, Cox C, Berman C, Clark R, Saba H, Wells K, Reintgen D. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg. 1991 Nov.162(5):432-437. Pubmedid: 1951904.
    • Norman J, Cox C, Cruse CW, Wells K, Reintgen D. A myocutaneous flap for closure of upper arm amputations for uncontrolled axillary tumors. J Surg Oncol. 1991 Aug.47(4):239-242. Pubmedid: 1861496.
    • Heller R, Wassalle J, Becker J, Cruse C, Wells K, Cox C, Reintgen D. The detection of submicroscopic lymph node metastases in patients with malignant melanoma. Arch Surg. 1991.126:1455-1460.
    • Cruse CW, Radocha RF. Squamous cell carcinoma of the lip. Plast Reconstr Surg. 1987 Dec.80(6):787-791. Pubmedid: 3685181.
    • Simpson LA, Cruse CW. Gasoline immersion injury. Plast Reconstr Surg. 1981 Jan.67(1):54-57. Pubmedid: 7443860.
    • Norman J, Wells K, Kearney R, Cruse CW, Berman C, Reintgen D. Identification of lymphatic drainage basins in patients with cutaneous melanoma. Semin Surg Oncol. 9(3):224-227. Pubmedid: 8516608.
    • Joseph E, Messina J, Glass FL, Cruse CW, Rapaport DP, Berman C, Greenberg H, Reintgen DS. Radioguided surgery for the ultrastaging of the patient with melanoma. Cancer J Sci Am. 3(6):341-345. Pubmedid: 9403046.
    • Riker A, Glass F, Perez I, Cruse C, Messina J, Sondak V. Cutaneous melanoma: methods of biopsy and definitive surgical excision. Dermatol Ther. 18(5):387-393. Pubmedid: 16297013.
  • Patient Comments

    Overall Satisfaction

    4.9

    255 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey

     

    Comments

    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor